T 0817/05 du 17.10.2007
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2007:T081705.20071017
- Date de la décision
- 17 octobre 2007
- Numéro de l'affaire
- T 0817/05
- Requête en révision de
- -
- Numéro de la demande
- 99939612.0
- Classe de la CIB
- A23L 1/30
- Langue de la procédure
- Anglais
- Distribution
- Distribuées aux présidents des chambres de recours (C)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- Antioxidant composition comprising Acetyl L-Carnitine and alpha-Lipoic Acid
- Nom du demandeur
- Sigma-Tau Healthscience S.p.A.
- Nom de l'opposant
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Chambre
- 3.3.09
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 54(3) 1973European Patent Convention Art 83 1973
- Mots-clés
- Main request, auxiliary requests 1-3: Novelty established by disclaimer (no)
Auxiliary request 4: Deletion of disclaimer: Reformatio in peius (no), Novelty (yes) - Exergue
- An amendment to a claim as allowed by the Opposition Division, by which a disclaimer was deleted together with the omission of an embodiment from which the disclaimer intended to exclude a novelty-anticipating disclosure in a document according to Article 54(3) EPC, does not put the Opponent and sole Appellant in a worse situation than if it had not appealed. The principle of the prohibition of "reformatio in peius" is not violated in accordance with G 1/99.
- Affaires citées
- G 0001/99
- Affaires citantes
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the set of Claims 1 to 12 of the 4th auxiliary request as filed during the oral proceedings after any necessary consequential amendments of the description.